智通财经APP获悉，兴业证券发布研报称，今年被多种因素压制较长时间的景气和质量因子重新领涨市场，代表主动公募平均业绩的两大指数跑赢多数宽 基，景气投资有效性显著提升。往后看，随着盈利预期改善、产业趋势演绎，适应景气投资的有利环境正逐步回归，景气的定价权重也有望持续提升。 兴业证券主要观点如下： 近年来，市场普遍感受是景气投资难度加大，与景气相关度较低的"哑铃型"配置成为市场的主要选择。但今年看到，被多种因素压制较长时间的景气和质 量因子重新领涨市场，代表主动公募平均业绩的两大指数跑赢多数宽基，景气投资有效性显著提升。 这背后，一方面是总量经济企稳修复、更多产业趋势逐渐形成后，中观和微观层面景气线索增多，为市场挖掘景气提供良好环境。今年以来，我国在 AI、机器人、半导体、军工、创新药、新消费等各类新动能领域实现突破，叠加更多传统周期和制造板块实现供给格局优化，新旧动能平稳转换下，景 气线索明显增多。25Q1高增长行业占比由2024年末的11.45%大幅抬升至22.14%，景气边际改善的上市公司数量占比升至2010年以来新高，为市场挖掘景 气提供良好环境。 此外，今年以来，擅长景气投资的机构资金对于市场参与热情显 ...

8月12日午后，港股三大指数涨跌不一。A股同赛道规模最大的恒生科技指数ETF（513180）跟随指数震 荡，持仓股中，快手、金蝶国际、哔哩哔哩、蔚来等跌幅居前，华虹、中芯国际、比亚迪电子等涨幅居 前，其中华虹、中芯国际午后均涨超5%。 （文章来源：每日经济新闻） 资金面上，截至8月11日，今年以来南向资金累计净流入已突破9000亿港元大关，刷新年度净流额历史 记录。港股热度不断攀升，资金积极布局科技板块。截至8月11日，恒生科技指数ETF（513180）近20 个交易日合计获净流入约36.25亿元。 今年以来，南向资金主要流向人工智能和新消费等核心资产。AI、新消费这两大赛道体现出新兴产业 的发展趋势和一定的稀缺性，有望进一步吸引资金加码，助推港股行情持续向好。公开信息显示，恒生 科技指数ETF（513180）标的指数囊括30家港股科技龙头，软硬科技兼备，成分股深度聚焦AI产业链的 上中下游，其中阿里、腾讯、小米、美团、中芯国际、比亚迪等有望成为中国科技股"七巨头"。没有港 股通账户的投资者或可通过恒生科技指数ETF（513180）一键布局中国AI核心资产。（场外联接A/C： 013402/013403）。 ...

港股科技ETF（代码：513020）跟踪的是港股通科技指数（代码：931573），该指数由中证指数有限公 司编制，从港股通范围内上市的科技行业公司中精选不超过50家优质企业作为成分股。该指数旨在全面 反映可通过港股通渠道投资的科技领域上市公司证券的整体表现，其成分股具有显著的成长潜力和市场 波动特征。 没有股票账户的投资者可关注国泰中证港股通科技ETF发起联接C（015740），国泰中证港股通科技 ETF发起联接A（015739）。 注：如提及个股仅供参考，不代表投资建议。指数/基金短期涨跌幅及历史表现仅供分析参考，不预示 未来表现。市场观点随市场环境变化而变动，不构成任何投资建议或承诺。文中提及指数仅供参考，不 构成任何投资建议，也不构成对基金业绩的预测和保证。如需购买相关基金产品，请选择与风险等级相 匹配的产品。基金有风险，投资需谨慎。 相关机构表示，2025年初以来，港股市场持续活跃，甚至一度领跑全球市场。在"资金盛、资产荒"的背 景下，港股日均成交额较去年同期增长约80%。对宏观不敏感的结构性行情尤为活跃：虽然整体中国基 本面趋弱且外部扰动不断，但结构性行情活跃，板块之间此消彼长、不断轮动，如年初以来 ...

11月8日，光大证券2024年度投资策略会在上海举行。会议以"改革创新 推动高质量发展"为主题， 邀请200家上市公司参与交流，涉及计算机、海外TMT、电新环保、医药等29个行业，开幕当日主论坛 参会人数近600人。 与会嘉宾还围绕经济回稳、半导体国产化、AI投资、自动驾驶、新消费等主题畅所欲言，共同探 讨资本市场投资新机遇，为投资者后续布局提供积极参考。 未来，光大证券研究所将进一步贯彻落实新发展理念，助力构建新发展格局，坚持专业研究、价值 挖掘，积极服务国家战略、服务实体经济、服务光大集团及公司发展，助力中国金融市场持续繁荣。 【纠错】 【责任编辑:柴峥】 光大证券总裁刘秋明出席会议并作开幕致辞。他表示，中央金融工作会议系统阐述了坚持走中国特 色金融发展之路的本质特征，为做好新时代金融工作明确了方向。服务实体经济是资本市场的本质。从 金融大国向金融强国迈进的新征程中，需要建设安全、规范、透明、开放、有活力、有韧性的资本市 场，激发企业创新，推动技术进步，促进资本形成，构建科技产业资本的高水平良性循环。光大证券始 终站稳人民立场，以直接融资服务企业客户，以财富管理服务个人客户，以研究和创新服务于机构客 户， ...

Group 1 - The core viewpoint of the article highlights that funds focused on innovative pharmaceuticals have seen significant gains, with some funds increasing over 61% in the first half of the year [1] - The top-performing funds include several that are primarily invested in innovative drugs, with the highest return being 86.48% for the fund "汇添富音港优势精选A" [1] - Other notable funds in the top 16 also show strong performance, with returns ranging from 61.77% to 83.15% [1] Group 2 - The article suggests that innovative drugs can be pursued when the market declines, indicating a potential buying opportunity [2] - The "广发成长领航一年持有A" fund has a significant portion of its holdings in new consumer concepts, with major investments in companies like 泡泡玛特 and 老铺黄金 [3] - The fund manager 吴远怡 has demonstrated strong performance across various products, with most showing commendable returns [4] Group 3 - The historical performance of the "广发科技创新" fund shows a maximum drawdown of -53%, indicating high volatility [5] - Overall, the funds discussed are characterized by high volatility and significant drawdowns, making them more suitable for investors willing to buy during market dips [7] - The article emphasizes that these funds may not be suitable for low-risk investors due to their performance characteristics [7]

Group 1 - Southbound capital continues to flow into the Hong Kong stock market, with net inflows exceeding HKD 900 billion this year, surpassing the total for 2024 and setting a historical record [1] - The capital is primarily directed towards core assets in artificial intelligence and new consumption, reflecting the development trend of emerging industries [1] - The trading activity in the Hong Kong stock market remains high, forming a positive cycle with Chinese assets [1] Group 2 - The Hong Kong technology sector, which has lagged recently, may soon see a rebound as major tech companies are set to disclose earnings in mid-August, with financial and core innovation indicators becoming crucial for validating AI prosperity [3] - Increased competition among internet platform companies has been fully priced into the market, laying the groundwork for a potential rebound [3] - The Hang Seng Technology Index includes 30 leading Hong Kong tech companies, focusing on various aspects of the AI industry chain, providing investors with opportunities to invest in core AI assets in China [4] Group 3 - Despite a potential short-term market fluctuation, structural opportunities still exist, driven by liquidity in the current weak economic recovery environment [4] - Changes in market risk appetite are influencing market dynamics, with a recent cooling of domestic policy expectations [4] - The scarcity characteristics of AI and new consumption sectors are likely to attract further capital, supporting a positive trend in the Hong Kong stock market [4]

8月12日早盘，恒生科技指数震荡走低后跌幅开始收窄。A股同赛道规模最大的恒生科技指数ETF （513180）小幅下跌，持仓股中，金蝶国际、快手、哔哩哔哩、地平线机器人等领跌，比亚迪电子、中 芯国际、蔚来等涨幅居前。 南向资金年内净流入超9000亿港元，主要流向人工智能和新消费等核心资产。AI、新消费这两大赛道 体现出新兴产业的发展趋势和一定的稀缺性，有望进一步吸引资金加码，助推港股行情持续向好。公开 信息显示，恒生科技指数ETF（513180）标的指数囊括30家港股科技龙头，软硬科技兼备，成分股深度 聚焦AI产业链的上中下游，其中阿里、腾讯、小米、美团、中芯国际、比亚迪等有望成为中国科技 股"七巨头"。没有港股通账户的投资者或可通过恒生科技指数ETF（513180）一键布局中国AI核心资 产。（场外联接A/C：013402/013403）。 招商证券在最新研报中指出，短期港股可能进入震荡阶段，8月重点关注港股科技股可能补涨的机会。 具体来看，在当前经济弱复苏/稳定复苏的环境下，流动性驱动仍然是股票市场的一个主要特点，市场 风险偏好的变化主导市场节奏，短期市场对国内政策预期有所降温。美元流动性方面，未来阶段市场 ...

Group 1 - Hong Kong stock indices opened lower on August 12, with the Hang Seng Tech Index experiencing significant fluctuations, dropping over 0.5% at one point [1] - Kuaishou has launched an independent "takeaway" entry on its group purchase page, allowing users to place orders through a third-party mini-program for delivery, indicating a strategic shift towards collaboration with partners like Meituan [1] - Kuaishou is focusing on a "traffic open + third-party co-construction" model to penetrate the takeaway market, aiming to promote quality dining products and expand into more categories in the future [1] Group 2 - Kuaishou is set to announce its earnings on August 21, with expectations of stable performance driven by improvements in advertising and AI capabilities [2] - According to Everbright Securities, Kuaishou's advertising business is anticipated to benefit from optimized investment strategies and enhanced AI material support, while e-commerce is expected to maintain rapid growth [2] - The adjusted net profit forecasts for Kuaishou for 2025-2027 are projected at 20.15 billion, 24.19 billion, and 27.76 billion yuan, reflecting slight increases from previous estimates [2] Group 3 - Year-to-date net inflows from southbound funds have exceeded 90 billion HKD, primarily directed towards core assets in AI and new consumption sectors, indicating a trend towards emerging industries [3] - The Hang Seng Tech Index ETF (513180) includes 30 leading Hong Kong tech companies, focusing on the AI industry chain, with potential key players identified as Alibaba, Tencent, Xiaomi, Meituan, SMIC, and BYD [3] - Investors without a Hong Kong Stock Connect account can access Chinese AI core assets through the Hang Seng Tech Index ETF (513180) [3]

8月12日早盘，港股三大指数集体低开，恒生指数跌0.33％，国企指数跌0.34％，恒生科技指数跌 0.59%。开盘后，A股同赛道规模最大的恒生科技指数ETF（513180）跟随指数下行，持仓股中，比亚 迪电子、华虹半导体、腾讯音乐等涨幅居前，地平线机器人、金蝶国际、阿里巴巴、百度集团、快手等 跌幅居前。 港股中报季正式开幕，腾讯控股将于8月13日（周三）港股盘后发布2025年Q2业绩报告。对于本季财 报，市场主要关注游戏业务的新增长，广告业务在视频号起量下的货币化表现和展望等。光大证券在此 前发布的业绩前瞻中指出，预测腾讯控股2025Q2实现营业收入1799.3亿元（YoY+11.7%）。主要受增值 服务中游戏业务、网络广告业务保持较快增长驱动。预测公司2025Q2毛利率55.1%（YoY+1.8pcts）， 毛利润990.8亿元（YoY+15.4%），本土游戏、视频号广告等高毛利业务贡献增加；预测公司经营利润 587.2亿元，同比增长15.7%，保持降本增效趋势的同时，AI大模型投入的开支或有提升。该机构称，腾 讯控股基本面仍为宏观弱恢复背景下相对强劲的互联网平台，后续游戏产品线丰富，南向资金有望在后 续回 ...

Core Viewpoint - The equity market is recovering as the Shanghai Composite Index surpasses 3600 points, leading to a surge in funds implementing purchase limits to manage inflows and protect existing investors' interests [1][9]. Fund Purchase Limits - Since August 1, a total of 261 funds have announced restrictions on large purchases, with 158 funds actively suspending large subscriptions. This includes 44 bond funds, 43 QDII funds, 34 equity funds, 29 mixed funds, 6 money market funds, and 2 FoFs [1]. - Specific funds, such as the China Europe Medical Innovation Fund, have set a daily purchase limit of 100,000 yuan to ensure stable operations and protect investors [2]. QDII Fund Adjustments - The National Foreign Exchange Administration issued a new batch of QDII investment quotas amounting to 3.08 billion USD, bringing the total QDII quota to 170.87 billion USD [4]. - Due to quota constraints, several QDII funds have adjusted their daily subscription limits, with some funds increasing their minimum purchase amounts significantly [7]. Performance and Strategy - High-performing funds are implementing purchase limits to control their scale and maintain investment strategy effectiveness. For instance, the China Europe Medical Innovation Fund has achieved a one-year return of 80.12% [8]. - The shift from focusing on fund size to prioritizing returns reflects a broader industry trend towards sustainable growth and investor protection [9]. Market Outlook - Despite the purchase limits, many fund companies remain optimistic about the market's long-term prospects, particularly in sectors like technology, manufacturing, and new consumption [10]. - Investment strategies are suggested to balance potential volatility, with a focus on sectors such as AI applications and advanced semiconductor processes, which are expected to benefit from supportive policies [11].